IPSC-derived cells offered by PELOBiotech

We offer a lot in the field of iPSC-derived cells, but what else does PELOBiotech offer?

We are more than competent4cells – especially when it comes to advanced disease modeling.

Using human iPSC technology, we generate a broad range of cell models tailored for drug discovery, biomarker development, diagnostics, and more. iPSC-derived cells offer a human-relevant alternative to animal models – ideal for studying complex diseases.

With access to over 10,000 human disease models, including spheroids, organoids, and barrier models, we offer diverse, application-ready cell types – from cardiomyocytes and hepatocytes to neurons, immune cells, endothelial cells, and more.

Whether you’re modeling neurodegeneration, testing cardiotoxicity, or exploring liver fibrosis – PELOBiotech is your trusted partner in iPSC-derived research.

Filter products

There are no entries on the watch list.

Advanced iPSC-derived cell models for translational research

PELOBiotech offers a wide range of iPSC-derived cells, including cardiomyocytes, hepatocytes, neurons, and more—ideal for disease modeling, drug discovery, and biomarker development. With over 10,000 human disease models available, we provide human-relevant, application-ready solutions to advance your translational and regenerative research.